Alethio raises $90M to target rare blood cancers
BioPharma DiveGwendolyn WuNovember 5, 2026
The startup is working on a medicine one of its investors claimed could have a broader reach than other approved drugs for a group of conditions known as myeloproliferative neoplasms.